(Q43857291)

27 November 2017

title

Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone (English)

1 reference

Cardiology and cardiovascular medicine

27 November 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

21 March 2024

1 reference

amiodarone

15 June 2024

K. Nademanee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7234654

21 March 2024

J. A. Hendrickson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7234654

21 March 2024

D. S. Cannom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7234654

21 March 2024

B. N. Goldreyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7234654

21 March 2024

B. N. Singh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7234654

21 March 2024

language of work or name

English

0 references

publication date

1 June 1981

1 reference

full work available at URL

27 November 2017

https://api.elsevier.com/content/article/PII:000287038190613X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

https://api.elsevier.com/content/article/PII:000287038190613X?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

21 March 2024

published in

American Heart Journal

1 reference

27 November 2017

volume

101

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

759-768

1 reference

Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia

27 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia

21 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Antiarrhythmic drug therapy in survivors of prehospital cardiac arrest: comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest

21 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Antiarrhythmic therapy, ventricular premature depolarizations and sudden cardiac death: the tip of the iceberg

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

New perspectives in the pharmacologic therapy of cardiac arrhythmias

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

21 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Treatment of recurrent symptomatic ventricular tachycardia

21 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

21 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Comparative mechanisms of action of antiarrhythmic drugs

21 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment

21 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Control of recurrent supraventricular tachycardia with amiodarone hydrochloride

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

21 March 2024

Q64869077

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Rational Basis of Antiarrhythmic Therapy: Clinical Pharmacology of Commonly Used Antiarrhythmic Drugs

21 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders

21 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Clinical efficacy of amiodarone as an antiarrhythmic agent

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Management of patients with malignant ventricular arrhythmias

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia

21 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials.

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

The adrenergic antagonism of amiodarone

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

The effects of amiodarone on the sinus node activity of the rabbit heart

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Effects of amiodarone on thyroid function in patients with ischaemic heart disease

21 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

The Prolonged QT Interval

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Amiodarone pigmentation. An electron microscopic study

21 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone

21 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

21 March 2024

Cornea verticillata

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(81)90613-X

21 March 2024

Identifiers

1 reference

27 November 2017

1 reference